Bifogade filer
PDF
Kurs & Likviditet
Kalender
| 2024-11-12 | Kvartalsrapport 2024-Q3 |
| 2024-08-13 | Kvartalsrapport 2024-Q2 |
| 2024-05-15 | Ordinarie utdelning MOB 0.00 SEK |
| 2024-05-14 | Årsstämma 2024 |
| 2024-05-07 | Kvartalsrapport 2024-Q1 |
| 2024-02-13 | Bokslutskommuniké 2023 |
| 2023-11-07 | Kvartalsrapport 2023-Q3 |
| 2023-10-09 | Extra Bolagsstämma 2023 |
| 2023-08-03 | Kvartalsrapport 2023-Q2 |
| 2023-05-24 | Split MOB 10:1 |
| 2023-05-17 | Ordinarie utdelning MOB 0.00 SEK |
| 2023-05-16 | Årsstämma 2023 |
| 2023-05-09 | Kvartalsrapport 2023-Q1 |
| 2023-02-07 | Bokslutskommuniké 2022 |
| 2022-11-08 | Kvartalsrapport 2022-Q3 |
| 2022-08-09 | Kvartalsrapport 2022-Q2 |
| 2022-05-17 | Ordinarie utdelning MOB 0.00 SEK |
| 2022-05-16 | Årsstämma 2022 |
| 2022-05-10 | Kvartalsrapport 2022-Q1 |
| 2022-05-03 | Extra Bolagsstämma 2022 |
| 2022-02-08 | Bokslutskommuniké 2021 |
| 2021-11-09 | Kvartalsrapport 2021-Q3 |
| 2021-08-10 | Kvartalsrapport 2021-Q2 |
| 2021-05-11 | Kvartalsrapport 2021-Q1 |
| 2021-03-31 | Ordinarie utdelning MOB 0.00 SEK |
| 2021-03-30 | Årsstämma 2021 |
| 2021-02-09 | Bokslutskommuniké 2020 |
| 2020-12-01 | Extra Bolagsstämma 2020 |
| 2020-05-12 | Kvartalsrapport 2020-Q3 |
| 2020-02-11 | Kvartalsrapport 2020-Q2 |
| 2019-11-19 | Kvartalsrapport 2020-Q1 |
| 2019-11-04 | Inlösen MOB 46.5 |
| 2019-10-31 | Ordinarie utdelning MOB 0.00 SEK |
| 2019-10-30 | Årsstämma 2020 |
| 2019-08-29 | Bokslutskommuniké 2019 |
| 2019-05-16 | Ordinarie utdelning MOB 0.00 SEK |
| 2019-05-15 | Årsstämma 2019 |
| 2019-05-14 | Kvartalsrapport 2019-Q1 |
| 2019-03-15 | Extra Bolagsstämma 2019 |
| 2019-02-12 | Bokslutskommuniké 2018 |
| 2018-11-06 | Kvartalsrapport 2018-Q3 |
| 2018-08-07 | Kvartalsrapport 2018-Q2 |
| 2018-05-16 | Ordinarie utdelning MOB 0.00 SEK |
| 2018-05-15 | Årsstämma 2018 |
| 2018-05-08 | Kvartalsrapport 2018-Q1 |
| 2018-02-13 | Bokslutskommuniké 2017 |
| 2017-11-13 | Kvartalsrapport 2017-Q3 |
| 2017-08-08 | Kvartalsrapport 2017-Q2 |
| 2017-05-17 | Ordinarie utdelning MOB 0.00 SEK |
| 2017-05-16 | Årsstämma 2017 |
| 2017-05-09 | Kvartalsrapport 2017-Q1 |
| 2017-02-14 | Bokslutskommuniké 2016 |
| 2016-11-08 | Kvartalsrapport 2016-Q3 |
| 2016-08-09 | Kvartalsrapport 2016-Q2 |
| 2016-05-19 | Ordinarie utdelning MOB 0.00 SEK |
| 2016-05-18 | Årsstämma 2016 |
| 2016-05-10 | Kvartalsrapport 2016-Q1 |
| 2016-02-17 | Bokslutskommuniké 2015 |
| 2015-11-10 | Kvartalsrapport 2015-Q3 |
| 2015-08-11 | Kvartalsrapport 2015-Q2 |
| 2015-05-12 | Ordinarie utdelning MOB 0.00 SEK |
| 2015-05-11 | Årsstämma 2015 |
| 2015-05-11 | Bokslutskommuniké 2014 |
| 2015-05-11 | Kvartalsrapport 2015-Q1 |
| 2015-02-27 | Bokslutskommuniké 2014 |
| 2014-11-14 | Kvartalsrapport 2014-Q3 |
| 2014-08-13 | Kvartalsrapport 2014-Q2 |
| 2014-05-14 | Ordinarie utdelning MOB 0.00 SEK |
| 2014-05-13 | Årsstämma 2014 |
| 2014-05-13 | Kvartalsrapport 2014-Q1 |
| 2014-02-20 | Bokslutskommuniké 2013 |
| 2013-11-05 | Kvartalsrapport 2013-Q3 |
| 2013-08-06 | Kvartalsrapport 2013-Q2 |
| 2013-05-21 | Kvartalsrapport 2013-Q1 |
| 2013-05-21 | Analytiker möte 2013 |
| 2013-04-24 | Ordinarie utdelning MOB 0.00 SEK |
| 2013-04-23 | Årsstämma 2013 |
| 2013-03-13 | 15-7 2013 |
| 2013-02-05 | Bokslutskommuniké 2012 |
| 2012-11-19 | Extra Bolagsstämma 2012 |
| 2012-10-25 | Kvartalsrapport 2012-Q3 |
| 2012-09-20 | Kapitalmarknadsdag 2012 |
| 2012-08-28 | Kvartalsrapport 2012-Q2 |
| 2012-06-11 | 15-7 2012 |
| 2012-04-24 | Ordinarie utdelning MOB 0.00 SEK |
| 2012-04-23 | Årsstämma 2012 |
| 2012-04-23 | Kvartalsrapport 2012-Q1 |
| 2012-02-09 | Bokslutskommuniké 2011 |
| 2011-11-29 | 15-7 2011 |
| 2011-10-28 | Kvartalsrapport 2011-Q3 |
| 2011-08-12 | Kvartalsrapport 2011-Q2 |
| 2011-04-18 | Kvartalsrapport 2011-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
STOCKHOLM, March 31[th], 2022. The exercise period for Moberg Pharma AB's (publ)'s ("Moberg Pharma" or the "Company") warrants of series 2020:1 ended 29 March 2022. In total, 2,339,396 warrants of series 2020:1 were exercised for subscription of in total 1,169,698 ordinary shares, corresponding to a subscription rate of approximately 10.1 percent. Moberg Pharma will thereby receive proceeds of approximately SEK 7,568,000 before issue costs.
Exercised warrants have been converted to interim shares (IA) until the new ordinary shares have been registered with the Swedish Companies Registration Office. The interim shares are not subject to any organized trading. Conversion of interim shares to ordinary shares in Moberg Pharma is expected to occur on or about 19 April 2022.
When the new shares have been registered with the Swedish Companies Registration Office, the total number of shares and votes in Moberg Pharma will amount to 46,681,123 and the share capital will amount to SEK 4,668,112.30. This entails a dilution of approximately 2.5 percent based on the number of shares and votes in Moberg Pharma after the exercise of warrants of series 2020:1.
About this information
The information was submitted for publication, through the agency of the contact persons set out above on 31 March 2022, at 13:00 CET.
Anna Ljung, CEO, telephone: +46 707 66 60 30, e-mail: anna.ljung@mobergpharma.se
Mark Beveridge, VP Finance, telephone: +46 768 05 82 88, e-mail: mark.beveridge@mobergpharma.se